Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
ID06581328

A Phase 4 Study Evaluating Vedolizumab for Moderate to Severely Active Ulcerative Colitis or Crohn's Disease in a Community Setting

Led by Takeda · Updated on 2026-05-29

400

Participants Needed

100

Research Sites

34 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying adults with moderate to severely active Ulcerative Colitis (UC) or Crohn's Disease (CD), which are long-term gut conditions causing symptoms like diarrhea, inflammation, bleeding, and belly pain. The study aims to evaluate how many participants achieve remission, meaning their signs and symptoms disappear, after 14 weeks of treatment with Vedolizumab. This is a Phase 4 trial sponsored by Takeda, focused on treatment in a community setting. Participants will receive Vedolizumab initially as an intravenous infusion at weeks 0 and 2. Around week 6, participants may switch to subcutaneous injections every two weeks until week 50. Some participants might receive an additional intravenous dose at week 6 before switching. Those whose treatment does not seem effective by week 14 may stop and switch to other therapies. Additional visits occur at weeks 26 and 52, with a final check 18 weeks after the last Vedolizumab dose. Throughout the study, participants will visit their clinic multiple times for assessments. Researchers will measure remission rates using patient-reported outcomes at various points, including weeks 6, 14, and 52. Other evaluations include clinical responses, endoscopic improvements, and changes in inflammation markers like C-reactive protein and fecal calprotectin. Safety is monitored by tracking infections and adverse events up to 72 weeks, ensuring comprehensive follow-up over approximately one year.

CONDITIONS

Brief Title

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant can understand and follow study requirements
  • Signed informed consent prior to study procedures
  • Aged 18 to 80 years at consent
  • Immunizations up to date per Vedolizumab prescribing information
  • Women of childbearing potential must use effective contraception, avoid donating eggs, have a negative pregnancy test before first dose, and avoid breastfeeding during and 18 weeks after treatment
  • Fertile men must use contraception and avoid donating sperm during and 18 weeks after treatment
  • Diagnosed with moderate to severely active UC or CD confirmed by clinical, endoscopic, and histopathology reports
  • Inadequate response, loss of response, or intolerance to corticosteroids, immunomodulators, or advanced therapies
Not Eligible

You will not qualify if you...

  • Prior use of approved or investigational anti-integrin antibodies before screening
  • Failed more than two prior advanced treatments
  • Use of corticosteroid enemas or suppositories within 2 weeks before screening
  • Contraindications or allergies to Vedolizumab or its ingredients
  • Use of investigational biologic therapy within 6 months before screening
  • Received advanced treatment for conditions other than UC or CD
  • Active infection at screening
  • Ileostomy, colostomy, severe or symptomatic intestinal stenosis, or short bowel syndrome
  • Recent major surgery within 3 months or planned surgery during the study
  • History of certain treated skin cancers or cervical carcinoma in situ without recurrence
  • History or symptoms of progressive multifocal leukoencephalopathy
  • Laboratory abnormalities during screening period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 50 weeks

Participants receive vedolizumab treatment starting with two intravenous infusions at Weeks 0 and 2, followed by subcutaneous injections every 2 weeks from Week 6 until Week 50. An additional intravenous dose may be given at Week 6 with mandatory transition to subcutaneous dosing by Week 14.

Visits every 2 weeks during treatment

Follow-up

Duration - Up to 22 weeks after treatment ends

Participants are monitored for safety and treatment outcomes after completing vedolizumab treatment.

Visits as scheduled until study completion

Trial Site Locations

Total: 100 locations

1

Gastro Health Research- St. Vincents East

Birmingham, Alabama, United States, 35235

Active, Not Recruiting

2

East View Medical Research

Mobile, Alabama, United States, 36608

Actively Recruiting

3

AZ Gastro Care

Chandler, Arizona, United States, 85225

Actively Recruiting

4

Spectrum Research Institute LLC

Gilbert, Arizona, United States, 85297

Actively Recruiting

5

GI Alliance- Sun City

Sun City, Arizona, United States, 85351

Actively Recruiting

6

UAMS Health Gastroenterology Clinic

Little Rock, Arkansas, United States, 72205

Withdrawn

7

Gastroenterology and Liver Institute

Escondido, California, United States, 92025

Actively Recruiting

8

Inland Empire Gastroenterology

Murrieta, California, United States, 92562

Withdrawn

9

United Clinical Research Institute

Murrieta, California, United States, 92563

Actively Recruiting

10

Digestive Health Institute

Newport Beach, California, United States, 92663

Withdrawn

11

Knowledge Research Center

Orange, California, United States, 92868

Withdrawn

12

Medical Associates Research Group, Inc.

San Diego, California, United States, 92123

Withdrawn

13

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States, 80907

Actively Recruiting

14

Associates in Gastroenterology, PC

Colorado Springs, Colorado, United States, 80923

Actively Recruiting

15

Rocky Mountain Endocopy Centers LLC

Littleton, Colorado, United States, 80120

Actively Recruiting

16

Access Research Institute

Brooksville, Florida, United States, 34613

Actively Recruiting

17

Gastro Florida

Clearwater, Florida, United States, 33762

Actively Recruiting

18

Doral Medical Research, LLC

Hialeah, Florida, United States, 33016

Withdrawn

19

Digestive and Liver Center of Florida, P.A.

Kissimmee, Florida, United States, 34741

Actively Recruiting

20

Gastro Health Research - Miami

Miami, Florida, United States, 33176

Actively Recruiting

21

The Clinical Trials Network CTNX LLC

Orange City, Florida, United States, 32763

Actively Recruiting

22

Endoscopic Research, Inc.

Orlando, Florida, United States, 32803

Actively Recruiting

23

Orlando Health-Orlando Regional Medical Center

Orlando, Florida, United States, 32806

Actively Recruiting

24

Digestive and Liver Center of Florida

Orlando, Florida, United States, 32825

Withdrawn

25

Gastro Health Research - Pensacola

Pensacola, Florida, United States, 32504

Actively Recruiting

26

West Central Gastroenterology d/b/a Gastro Florida

Pinellas Park, Florida, United States, 33781

Actively Recruiting

27

Digestive Healthcare of Georgia

Atlanta, Georgia, United States, 30327

Actively Recruiting

28

AGA GA Research LLC

Atlanta, Georgia, United States, 30342

Actively Recruiting

29

Atlanta Center for Gastroenterology, P.C.

Decatur, Georgia, United States, 30033

Withdrawn

30

Yapp, Rockford M.D. (Private Practice)

Downers Grove, Illinois, United States, 60515

Actively Recruiting

31

GI Alliance - Glenview

Glenview, Illinois, United States, 60026

Actively Recruiting

32

Gastroenterology and Internal Medicine Specialists, SC

Lake Barrington, Illinois, United States, 60010

Actively Recruiting

33

Suburban Gastroenterology

Naperville, Illinois, United States, 60540

Withdrawn

34

GI Partners of Illinois - Southwest Gastroenterology

Oak Lawn, Illinois, United States, 60453

Actively Recruiting

35

Rockford Gastroenterology Associates, Ltd.

Rockford, Illinois, United States, 61107

Actively Recruiting

36

Springfield Clinic

Springfield, Illinois, United States, 62703

Actively Recruiting

37

Hutchinson Clinic

Hutchinson, Kansas, United States, 67502

Actively Recruiting

38

Tri-State Gastroenterology Associates

Crestview Hills, Kentucky, United States, 41017

Actively Recruiting

39

Baton Rouge General Medical Center - Bluebonnet Campus

Baton Rouge, Louisiana, United States, 70809

Actively Recruiting

40

Combined Gastro LLC

Lafayette, Louisiana, United States, 70503

Actively Recruiting

41

GI Alliance

Metairie, Louisiana, United States, 70006

Actively Recruiting

42

Portland Gastroenterology Center

Portland, Maine, United States, 04101

Actively Recruiting

43

Capital Digestive Care

Chevy Chase, Maryland, United States, 20815

Actively Recruiting

44

Woodholme Gastroenterology

Glen Burnie, Maryland, United States, 21061

Actively Recruiting

45

Gastro Health Research - Framingham

Framingham, Massachusetts, United States, 01702

Actively Recruiting

46

Lucida Clinical Trials LLC

New Bedford, Massachusetts, United States, 02740

Actively Recruiting

47

Gastroenterology Associates of Western Michigan, P.L.C.

Wyoming, Michigan, United States, 49519

Actively Recruiting

48

Huron Gastro

Ypsilanti, Michigan, United States, 48197

Actively Recruiting

49

MNGI Digestive Health, P.A.

Plymouth, Minnesota, United States, 55446

Withdrawn

50

Delta Gastroenterology and Endoscopy Center

Southaven, Mississippi, United States, 38671

Actively Recruiting

51

SSM Health Medical Group

Bridgeton, Missouri, United States, 63044

Active, Not Recruiting

52

GI Associates Research, LLC

Columbia, Missouri, United States, 65201

Actively Recruiting

53

Mid America Gastro Intestinal Consultants

Kansas City, Missouri, United States, 64111

Actively Recruiting

54

St Charles Clinical Research

Weldon Spring, Missouri, United States, 63304

Actively Recruiting

55

Advanced Research Institute

Reno, Nevada, United States, 89511

Withdrawn

56

Presbyterian Health care services

Albuquerque, New Mexico, United States, 87107

Withdrawn

57

Westchester Putnam Gastroenterology PC

Carmel, New York, United States, 10512

Actively Recruiting

58

Five Towns Gastroenterology

Cedarhurst, New York, United States, 11516

Active, Not Recruiting

59

IMIDeology

Elmhurst, New York, United States, 11373

Actively Recruiting

60

Intercity Gastroenterology

Fresh Meadows, New York, United States, 11040

Active, Not Recruiting

61

NYU Langone Long Island Clinical Research Associates

Lake Success, New York, United States, 11042

Withdrawn

62

Lenox Hill Hospital

New York, New York, United States, 10075

Withdrawn

63

New York Gastroenterology Associates

New York, New York, United States, 10075

Actively Recruiting

64

Manhattan Clinical Research, LLC

New York, New York, United States, 10279

Withdrawn

65

Gastroenterology Group of Rochester

Rochester, New York, United States, 14620

Withdrawn

66

ProHealth (Seaford) (Optum)

Seaford, New York, United States, 11783

Actively Recruiting

67

Syracuse VA Medical Center

Syracuse, New York, United States, 13210

Withdrawn

68

Digestive Disease Medicine

Utica, New York, United States, 13502

Actively Recruiting

69

Charlotte Gastroenterology and Hepatology, P.L.L.C

Charlotte, North Carolina, United States, 28207

Actively Recruiting

70

Pinehurst Medical Clinic Inc

Pinehurst, North Carolina, United States, 28374

Withdrawn

71

Piedmont Healthcare

Statesville, North Carolina, United States, 28625

Actively Recruiting

72

Wilmington Gastroenterology Associates

Wilmington, North Carolina, United States, 28403

Actively Recruiting

73

Gastro Health Research - Cincinnati

Cincinnati, Ohio, United States, 45219

Actively Recruiting

74

DSI Research Northridge LLC

Dayton, Ohio, United States, 45414

Actively Recruiting

75

Gastro Health Research - Liberty Township

Liberty Township, Ohio, United States, 45044

Actively Recruiting

76

Great Lakes Gastroenterology Research, LLC

Mentor, Ohio, United States, 44060

Actively Recruiting

77

DSI Research LLC

Springboro, Ohio, United States, 45066

Actively Recruiting

78

NorthShore Gastroenterology Research, LLC

Westlake, Ohio, United States, 44145

Actively Recruiting

79

The Oregon Clinic, P.C.

Portland, Oregon, United States, 97220

Actively Recruiting

80

University Gastroenterology

Providence, Rhode Island, United States, 02904

Actively Recruiting

81

Palmetto Primary Care Physician Division of Gastroenterology

Summerville, South Carolina, United States, 29486

Actively Recruiting

82

Sanford Center for Digestive Health

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

83

Tri-Cities Gastroenterology

Kingsport, Tennessee, United States, 37663

Actively Recruiting

84

The Clinical Trials Network CTNX LLC

El Paso, Texas, United States, 79936

Actively Recruiting

85

Amel Med LLC

Georgetown, Texas, United States, 78628

Actively Recruiting

86

Kelsey Research Foundation

Houston, Texas, United States, 77005

Actively Recruiting

87

MedCare Pharma LLC

Houston, Texas, United States, 77079

Actively Recruiting

88

Integrity Advanced Therapeutics

Houston, Texas, United States, 77090

Withdrawn

89

Spring Clinical Research

Houston, Texas, United States, 77090

Active, Not Recruiting

90

Gastro Health & Nutrition

Katy, Texas, United States, 77494

Active, Not Recruiting

91

One of a Kind Clinical Research Center LLC

Kingwood, Texas, United States, 77339

Actively Recruiting

92

West Texas Research Institute

Lubbock, Texas, United States, 79424

Actively Recruiting

93

Texas Gastro Consultants

Tomball, Texas, United States, 77375

Withdrawn

94

Digestive Research of Central Texas, LLC

Waco, Texas, United States, 76712

Actively Recruiting

95

GI Alliance - Webster

Webster, Texas, United States, 77598

Actively Recruiting

96

Advanced Research Institute

Ogden, Utah, United States, 84405

Withdrawn

97

Gastroenterology Consultants of Southwest Virginia.

Roanoke, Virginia, United States, 24014

Actively Recruiting

98

Centricity Research VIR - DBA IACT Health Virginia Gastroenterology Institute Research

Suffolk, Virginia, United States, 23435

Withdrawn

99

TMPG Clinical Research

Williamsburg, Virginia, United States, 23188

Withdrawn

100

GI Alliance

Bellevue, Washington, United States, 98405

Actively Recruiting

Loading map...

Research Team

T

Takeda Contact

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Gallium-68-labeled Fibroblast Activation Protein Inhibitor-4...

Crohn's Disease

Actively Recruiting

1 location

A Biospecimen Collection Study to Identify the Targets of Di...

Autoimmune Diseases

Actively Recruiting

12 locations

A Phase 2 Open-Label Extension Trial Evaluating Long-term Sa...

Crohn's Disease

Actively Recruiting

16 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here